Yahoo Web Search

    21.10N/A (N/A%)

    at Thu, Jun 28, 2018, 12:45PM EST - U.S. Markets open in 5 hrs 21 mins

    Pre Mkt N/A

    • Ask Price 0.00
    • Bid Price 0.00
    • P/E 17.25
    • 52 Wk. High 21.10
    • 52 Wk. Low 0.00
    • Mkt. Cap 9.07B
  1. Web results

  2. Sumitomo Dainippon Pharma - Wikipedia

    Sumitomo Dainippon Pharma Co., Ltd. (大日本住友製薬株式会社, Dainippon Sumitomo Seiyaku Kabushiki-Gaisha) is a pharmaceutical company based in Japan.Its headquarters are in Chuo-ku, Osaka.

  3. United States Court of Appeals for the Federal Circuit

    SUMITOMO DAINIPPON PHARMA CO. v. EMCURE PHARM. LTD. 3 . active pharmaceutical ingredient in each party’s commer-cial product, we need not determine what else falls within

  4. Information for Sumitomo Dainippon Pharma's shareholders and investors, such as financial data and the IR Library which includes the managerial policy and financial results summaries.

  5. Stock analysis for Sumitomo Dainippon Pharma Co Ltd (4506:Tokyo) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  6. SUNOVION and are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd. ...

  7. Sumitomo Dainippon Pharma Co Ltd (4506.T) Quote|

    Sumitomo Dainippon Pharma Co., Ltd., is a pharmaceutical company. The Japan segment manufactures and sells ethical and general use drugs. The North America segment manufactures, develops, purchases and sells ethical drugs.

  8. Sumitomo Dainippon Pharma Co Ltd (4506.T) -

    Connect to the most current information on stocks and bonds on for 4506.T

  9. Boston Biomedical - Home


    Sumitomo Dainippon Pharma; Boston Biomedical is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd. ...

  10. Sumitomo Dainippon Pharma Co Ltd, 4506:TYO profile -

    Sumitomo Dainippon Pharma Co Ltd (4506:TYO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.